This Biotech Stock 135% Jump Trims $44M: What Now Today
A biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Review which Dividend Aristocrats ETF has the highest management fee and how it affects net performance.
28,021 articlesA biotech stock that surged 135% in a year suddenly sees a big investor trim its stake by about $44 million. Here’s h...
Greg Abel, stepping into Warren Buffett's shoes, is quietly steering Berkshire Hathaway toward tech-driven bets. A bi...
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Chips led a broad market dip at midday as investors weighed AI headlines against inflation risks and possible rate hi...
Tech stocks have cooled, but Meta Platforms may offer a patient investor a compelling setup. This guide breaks down w...
One large investor dumped 783,379 Truth Social shares, triggering a sharp move in the stock. This article explains wh...
When a major holder severs a stake in a big airline, it signals shifts in sentiment. We break down what cobalt capita...
SpaceX faced its first red day since its IPO, dropping about 5% as broad markets slipped. This article breaks down wh...
AI megatrends are reshaping portfolios, and Robinhood users are flocking to chipmakers. This guide highlights the thr...
When a long-time investor dumps a big stake, questions follow. This guide breaks down what an insider sale means for ...
I run my investments on my own, but I still reserve a passive sleeve to reduce risk and simplify life. This is how I ...
May presents a compelling setup for investors seeking durable growth. This guide breaks down the three key reasons wh...